v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
General and administrative $ 696,635 $ 337,445 $ 1,501,998 $ 355,273
Research and development 668,636 1,106,876
Total operating expenses 1,365,271 337,445 2,608,874 355,273
Loss from operations (1,365,271) (337,445) (2,608,874) (355,273)
Other income (expense):        
Change in fair value of SAFE notes 726,850 (241,300)
Interest income 237 12 410 821
Net (loss) income $ (1,365,034) $ 389,417 $ (2,608,464) $ (595,752)
Net loss per common share - basic $ (0.06) $ 0.15 $ (0.13) $ (0.25)
Net loss per common share - diluted $ (0.06) $ 0.15 $ (0.13) $ (0.25)
Weighted average common shares outstanding - basic 21,818,476 2,584,135 20,174,547 2,405,559
Weighted average common shares outstanding - dilutive 21,818,476 2,584,135 20,174,547 2,405,559